Aveanna Price To Sales Ratio from 2010 to 2024

AVAH Stock  USD 5.58  0.01  0.18%   
Aveanna Healthcare's Price To Sales Ratio is decreasing with slightly volatile movements from year to year. Price To Sales Ratio is predicted to flatten to 0.09. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing Aveanna Healthcare's market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
0.0931
Current Value
0.0885
Quarterly Volatility
0.43481917
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Aveanna Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aveanna Healthcare's main balance sheet or income statement drivers, such as Tax Provision of 21.9 K, Interest Income of 481.4 K or Depreciation And Amortization of 32.9 M, as well as many indicators such as Price To Sales Ratio of 0.0885, Dividend Yield of 0.0 or Days Sales Outstanding of 51.89. Aveanna financial statements analysis is a perfect complement when working with Aveanna Healthcare Valuation or Volatility modules.
  
Check out the analysis of Aveanna Healthcare Correlation against competitors.

Latest Aveanna Healthcare's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Aveanna Healthcare Holdings over the last few years. Price to Sales Ratio is figured by comparing Aveanna Healthcare stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Aveanna Healthcare sales, a figure that is much harder to manipulate than other Aveanna Healthcare Holdings multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Aveanna Healthcare's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aveanna Healthcare's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.54 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

Aveanna Price To Sales Ratio Regression Statistics

Arithmetic Mean0.77
Geometric Mean0.57
Coefficient Of Variation56.67
Mean Deviation0.27
Median0.81
Standard Deviation0.43
Sample Variance0.19
Range1.5308
R-Value(0.35)
Mean Square Error0.18
R-Squared0.12
Significance0.21
Slope(0.03)
Total Sum of Squares2.65

Aveanna Price To Sales Ratio History

2024 0.0885
2023 0.0931
2022 0.081
2020 1.49
2019 1.61

About Aveanna Healthcare Financial Statements

Investors use fundamental indicators, such as Aveanna Healthcare's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Aveanna Healthcare's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Price To Sales Ratio 0.09  0.09 

Currently Active Assets on Macroaxis

When determining whether Aveanna Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aveanna Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aveanna Healthcare Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aveanna Healthcare Holdings Stock:
Check out the analysis of Aveanna Healthcare Correlation against competitors.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aveanna Healthcare. If investors know Aveanna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aveanna Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.46)
Earnings Share
(0.35)
Revenue Per Share
10.315
Quarterly Revenue Growth
0.065
Return On Assets
0.0488
The market value of Aveanna Healthcare is measured differently than its book value, which is the value of Aveanna that is recorded on the company's balance sheet. Investors also form their own opinion of Aveanna Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Aveanna Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aveanna Healthcare's market value can be influenced by many factors that don't directly affect Aveanna Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aveanna Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aveanna Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aveanna Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.